Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ambrx Biopharma Inc. | Director | Ordinary Shares | 85K | $786K | $9.24 | Jun 7, 2023 | Direct |
International Stem Cell CORP | Director | Stock Option (Right to Buy) | 361K | Jun 11, 2024 | Direct | ||
Eton Pharmaceuticals, Inc. | Director | Stock Option (Right to buy) | 165K | Feb 13, 2024 | Direct | ||
Ambrx Biopharma, Inc. | Director | Restricted Stock Units | 0 | Mar 7, 2024 | Direct | ||
Ambrx Biopharma, Inc. | Director | Option to Purchase Common Stock | 0 | Mar 7, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ISCO.OB | International Stem Cell CORP | Jun 11, 2024 | 2 | $0 | 4 | Jun 13, 2024 | Director |
AMAM | Ambrx Biopharma, Inc. | Mar 7, 2024 | 3 | $0 | 4 | Mar 7, 2024 | Director |
ETON | Eton Pharmaceuticals, Inc. | Feb 13, 2024 | 1 | $0 | 4 | Feb 15, 2024 | Director |
ISCO | International Stem Cell CORP | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
AMAM | Ambrx Biopharma Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 9, 2023 | Director |
ETON | Eton Pharmaceuticals, Inc. | Mar 3, 2023 | 1 | $0 | 4 | Mar 3, 2023 | Director |
AMAM | Ambrx Biopharma Inc. | Jan 27, 2023 | 4 | $0 | 4 | Jan 31, 2023 | Director |
AMAM | Ambrx Biopharma Inc. | Jan 1, 2023 | 0 | $0 | 3 | Jan 3, 2023 | Director |
ISCO | International Stem Cell CORP | Jun 9, 2022 | 2 | $0 | 4 | Jun 10, 2022 | Director |
ETON | Eton Pharmaceuticals, Inc. | Feb 7, 2022 | 1 | $0 | 4 | Feb 28, 2022 | Director |
ISCO | International Stem Cell CORP | Jun 9, 2021 | 2 | $0 | 4 | Jun 11, 2021 | Director |